Inventory Summary of Quest Diagnostics Incorporated

Quest Diagnostics Incorporated's latest annual inventory in 2023 was 190 Million USD , down -1.04% from previous year.
Quest Diagnostics Incorporated's latest quarterly inventory in 2024 Q3 was 184 Million USD , up 1.1% from previous quarter.
Quest Diagnostics Incorporated reported annual inventory of 192 Million USD in 2022, down -7.69% from previous year.
Quest Diagnostics Incorporated reported annual inventory of 208 Million USD in 2021, down -6.73% from previous year.
Quest Diagnostics Incorporated reported quarterly inventory of 181 Million USD for 2024 Q1, down -4.74% from previous quarter.
Quest Diagnostics Incorporated reported quarterly inventory of 184 Million USD for 2024 Q3, up 1.1% from previous quarter.

Annual Inventory Chart of Quest Diagnostics Incorporated (2023 - 1996)

Historical Annual Inventory of Quest Diagnostics Incorporated (2023 - 1996)

Year	Inventory	Inventory Growth
2023	190 Million USD	-1.04%
2022	192 Million USD	-7.69%
2021	208 Million USD	-6.73%
2020	223 Million USD	81.3%
2019	123 Million USD	24.24%
2018	99 Million USD	4.21%
2017	95 Million USD	15.85%
2016	82 Million USD	-2.38%
2015	84 Million USD	-23.64%
2014	110 Million USD	20.88%
2013	91 Million USD	-2.26%
2012	93.1 Million USD	4.49%
2011	89.1 Million USD	16.32%
2010	76.6 Million USD	-16.19%
2009	91.4 Million USD	-10.48%
2008	102.1 Million USD	7.21%
2007	95.23 Million USD	21.22%
2006	78.56 Million USD	0.8%
2005	77.93 Million USD	3.47%
2004	75.32 Million USD	3.92%
2003	72.48 Million USD	19.02%
2002	60.89 Million USD	22.03%
2001	49.9 Million USD	12.72%
2000	44.27 Million USD	-15.35%
1999	52.3 Million USD	67.63%
1998	31.2 Million USD	2.63%
1997	30.4 Million USD	6.58%
1996	28.52 Million USD	0.0%

Year	Inventory	Inventory Growth
2024 Q2	182 Million USD	0.55%
2024 Q1	181 Million USD	-4.74%
2024 Q3	184 Million USD	1.1%
2023 Q3	184 Million USD	0.0%
2023 Q2	184 Million USD	-3.16%
2023 FY	190 Million USD	-1.04%
2023 Q1	190 Million USD	-1.04%
2023 Q4	190 Million USD	3.26%
2022 Q4	192 Million USD	4.92%
2022 FY	192 Million USD	-7.69%
2022 Q3	183 Million USD	-2.14%
2022 Q2	187 Million USD	-5.08%
2022 Q1	197 Million USD	-5.29%
2021 Q1	223 Million USD	0.0%
2021 FY	208 Million USD	-6.73%
2021 Q2	199 Million USD	-10.76%
2021 Q3	205 Million USD	3.02%
2021 Q4	208 Million USD	1.46%
2020 Q3	205 Million USD	33.12%
2020 Q1	126 Million USD	2.44%
2020 Q4	223 Million USD	8.78%
2020 Q2	154 Million USD	22.22%
2020 FY	223 Million USD	81.3%
2019 Q4	123 Million USD	9.82%
2019 FY	123 Million USD	24.24%
2019 Q2	105 Million USD	7.14%
2019 Q3	112 Million USD	6.67%
2019 Q1	98 Million USD	-1.01%
2018 Q2	91 Million USD	-3.19%
2018 Q4	99 Million USD	4.21%
2018 FY	99 Million USD	4.21%
2018 Q1	94 Million USD	-1.05%
2018 Q3	95 Million USD	4.4%
2017 Q1	77 Million USD	-6.1%
2017 Q2	83 Million USD	7.79%
2017 FY	95 Million USD	15.85%
2017 Q4	95 Million USD	-5.0%
2017 Q3	100 Million USD	20.48%
2016 FY	82 Million USD	-2.38%
2016 Q4	82 Million USD	0.0%
2016 Q3	82 Million USD	2.5%
2016 Q2	80 Million USD	-2.44%
2016 Q1	82 Million USD	-2.38%
2015 Q1	106 Million USD	-3.64%
2015 Q2	109 Million USD	2.83%
2015 Q4	84 Million USD	-2.33%
2015 Q3	86 Million USD	-21.1%
2015 FY	84 Million USD	-23.64%
2014 Q3	111 Million USD	1.83%
2014 FY	110 Million USD	20.88%
2014 Q4	110 Million USD	-0.9%
2014 Q2	109 Million USD	10.1%
2014 Q1	99 Million USD	8.79%
2013 Q2	89.4 Million USD	-0.45%
2013 FY	91 Million USD	-2.26%
2013 Q1	89.8 Million USD	-3.54%
2013 Q4	91 Million USD	6.81%
2013 Q3	85.2 Million USD	-4.7%
2012 Q4	93.1 Million USD	-1.48%
2012 FY	93.1 Million USD	4.49%
2012 Q2	90.1 Million USD	2.04%
2012 Q1	88.3 Million USD	-0.93%
2012 Q3	94.5 Million USD	4.88%
2011 Q3	85 Million USD	-3.41%
2011 Q2	88 Million USD	22.73%
2011 Q1	71.7 Million USD	-6.36%
2011 FY	89.1 Million USD	16.32%
2011 Q4	89.13 Million USD	4.86%
2010 Q2	78.4 Million USD	-1.38%
2010 Q1	79.5 Million USD	-13.01%
2010 FY	76.6 Million USD	-16.19%
2010 Q4	76.57 Million USD	4.61%
2010 Q3	73.2 Million USD	-6.63%
2009 Q3	80.9 Million USD	1.49%
2009 Q1	86.5 Million USD	-15.3%
2009 Q2	79.71 Million USD	-7.84%
2009 Q4	91.38 Million USD	12.96%
2009 FY	91.4 Million USD	-10.48%
2008 FY	102.1 Million USD	7.21%
2008 Q4	102.12 Million USD	3.35%
2008 Q1	97.36 Million USD	2.24%
2008 Q3	98.81 Million USD	0.5%
2008 Q2	98.33 Million USD	0.99%
2007 Q4	95.23 Million USD	3.01%
2007 Q1	87.71 Million USD	11.65%
2007 Q3	92.44 Million USD	-4.54%
2007 Q2	96.83 Million USD	10.4%
2007 FY	95.23 Million USD	21.22%
2006 Q3	77.31 Million USD	8.19%
2006 FY	78.56 Million USD	0.8%
2006 Q1	77.91 Million USD	-0.03%
2006 Q2	71.46 Million USD	-8.28%
2006 Q4	78.56 Million USD	1.62%
2005 Q3	78.17 Million USD	2.5%
2005 Q4	77.93 Million USD	-0.3%
2005 Q2	76.26 Million USD	0.01%
2005 Q1	76.26 Million USD	1.24%
2005 FY	77.93 Million USD	3.47%
2004 Q1	72.62 Million USD	0.19%
2004 FY	75.32 Million USD	3.92%
2004 Q4	75.32 Million USD	2.88%
2004 Q3	73.21 Million USD	0.51%
2004 Q2	72.84 Million USD	0.31%
2003 Q1	67.06 Million USD	10.13%
2003 Q4	72.48 Million USD	5.93%
2003 Q2	68.48 Million USD	2.11%
2003 Q3	68.42 Million USD	-0.08%
2003 FY	72.48 Million USD	19.02%
2002 FY	60.89 Million USD	22.03%
2002 Q3	59.01 Million USD	1.87%
2002 Q4	60.89 Million USD	3.19%
2002 Q2	57.93 Million USD	12.41%
2002 Q1	51.53 Million USD	3.26%
2001 Q1	45.16 Million USD	2.0%
2001 Q2	44.45 Million USD	-1.56%
2001 Q4	49.9 Million USD	8.05%
2001 Q3	46.18 Million USD	3.9%
2001 FY	49.9 Million USD	12.72%
2000 Q3	43.01 Million USD	-10.11%
2000 Q1	49.9 Million USD	-4.58%
2000 Q2	47.84 Million USD	-4.12%
2000 FY	44.27 Million USD	-15.35%
2000 Q4	44.27 Million USD	2.93%
1999 Q4	52.3 Million USD	1.75%
1999 Q3	51.4 Million USD	56.23%
1999 Q1	33 Million USD	5.77%
1999 FY	52.3 Million USD	67.63%
1999 Q2	32.9 Million USD	-0.3%
1998 FY	31.2 Million USD	2.63%
1998 Q2	29.2 Million USD	-2.67%
1998 Q3	29.8 Million USD	2.05%
1998 Q4	31.2 Million USD	4.7%
1998 Q1	30 Million USD	-1.32%
1997 FY	30.4 Million USD	6.58%
1997 Q4	30.4 Million USD	4.11%
1997 Q2	27.9 Million USD	-2.45%
1997 Q3	29.2 Million USD	4.66%
1997 Q1	28.6 Million USD	-1.38%
1996 Q3	26 Million USD	0.0%
1996 FY	28.52 Million USD	0.0%
1996 Q4	29 Million USD	11.54%

Peer Inventory Comparison of Quest Diagnostics Incorporated

Name	Inventory	Inventory Difference
Agilent Technologies, Inc.	1.03 Billion USD	81.571%
Charles River Laboratories International, Inc.	380.25 Million USD	50.034%
Danaher Corporation	2.59 Billion USD	92.675%
Enzo Biochem, Inc.	6.83 Million USD	-2681.03%
IQVIA Holdings Inc.	- USD	-Infinity%
Laboratory Corporation of America Holdings	474.6 Million USD	59.966%
Mettler-Toledo International Inc.	385.86 Million USD	50.76%
Qiagen N.V.	398.38 Million USD	52.307%
Revvity, Inc.	428.06 Million USD	55.614%
Thermo Fisher Scientific Inc.	5.08 Billion USD	96.266%
Waters Corporation	516.23 Million USD	63.195%

Global Stocks Search

Quest Diagnostics Incorporated (DGX)

Inventory Summary of Quest Diagnostics Incorporated

Annual Inventory Chart of Quest Diagnostics Incorporated (2023 - 1996)

Historical Annual Inventory of Quest Diagnostics Incorporated (2023 - 1996)

Peer Inventory Comparison of Quest Diagnostics Incorporated